Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Micro-fragmented collagen hydrogel wound dressing: Enhanced porosity facilitates elevated stem cell survival and paracrine effects for accelerated wound maturation.

Hong C., Lee Y., Chung H., Kim D., Kim J., Kim JW.

Animal Study on Chronic Wound, published in Mater Today Bio (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mater Today Bio (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40225133
PMCID
PMC11986482
DOI
10.1016/j.mtbio.2025.101678
Citations
8

Abstract (original English)

Human Adipose-derived stem cells (hADSCs), known for their mesenchymal stem cell properties, including multilineage differentiation and self-renewal, hold significant promise for chronic wound regeneration. Typically, hADSCs are utilized in cellular aggregates or hydrogels to enhance therapeutic efficacy. However, limitations such as reduced cell viability, inadequate mass transfer rates, and diminished paracrine effects hinder their clinical applications. This study explores an innovative approach by encapsulating hADSCs within a collagen/hyaluronic acid micro-fragmented collagen hydrogel wound dressing (MCWD). The resulting micro-fragmented collagen hydrogel-hADSC composite created through the integration of micro-sized hydrogel units and cells demonstrated markedly improved cell viability and activity, as well as superior therapeutic outcomes compared to conventional cell aggregates (CA) and collagen hydrogel wound dressings (CWD ). In vitro assessments showed that the highly porous structure of MCWD promotes better mass transfer and enhances the viability and cytokine production of hADSCs associated with the paracrine effect. In vivo experiments further validated the effectiveness of the MCWD, revealing significant enhancements in cell proliferation, skin thickness restoration, collagen maturation, and blood vessel formation. These findings underscore the potential of MCWD

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research